Wall Street Experts
ver. ZuMIgo(08/25)
Innate Pharma S.A.
Rachunek Zysków i Strat
Przychody TTM (mln): 34
EBIT TTM (mln): -39
index |
0 |
1 |
2 |
3 |
4 |
5 |
6 |
7 |
8 |
9 |
10 |
11 |
12 |
13 |
14 |
15 |
16 |
17 |
18 |
19 |
Rok finansowy |
2005 |
2006 |
2007 |
2008 |
2009 |
2010 |
2011 |
2012 |
2013 |
2014 |
2015 |
2016 |
2017 |
2018 |
2019 |
2020 |
2021 |
2022 |
2023 |
2024 |
Przychód (mln) |
1 |
6 |
14 |
13 |
8 |
4 |
12 |
10 |
12 |
1 |
18 |
56 |
33 |
80 |
69 |
57 |
12 |
50 |
52 |
13 |
Przychód Δ r/r |
0.0% |
376.5% |
130.7% |
-9.6% |
-40.3% |
-44.0% |
171.8% |
-11.6% |
20.2% |
-92.7% |
1874.2% |
213.6% |
-41.9% |
144.8% |
-13.7% |
-17.6% |
-78.7% |
309.8% |
4.6% |
-75.7% |
Marża brutto |
27.4% |
64.5% |
80.6% |
80.2% |
56.6% |
20.7% |
86.0% |
33.9% |
39.2% |
-1232.6% |
100.0% |
100.0% |
100.0% |
100.0% |
34.5% |
94.6% |
-288.1% |
-4.1% |
100.0% |
100.0% |
EBIT (mln) |
-6 |
-7 |
-9 |
-11 |
-16 |
-14 |
-8 |
-3 |
-3 |
-20 |
-11 |
8 |
-40 |
5 |
-27 |
-14 |
-48 |
-12 |
-22 |
-52 |
EBIT Δ r/r |
0.0% |
12.8% |
25.6% |
21.1% |
41.2% |
-11.9% |
-44.7% |
-55.3% |
-17.5% |
614.9% |
-46.0% |
-170.3% |
-628.1% |
-112.9% |
-625.7% |
-49.4% |
249.3% |
-75.6% |
92.3% |
130.2% |
EBIT (%) |
-493.5% |
-116.9% |
-63.6% |
-85.2% |
-201.3% |
-316.9% |
-64.5% |
-32.6% |
-22.4% |
-2201.3% |
-60.2% |
13.5% |
-122.5% |
6.4% |
-39.2% |
-24.1% |
-394.9% |
-23.5% |
-43.2% |
-408.6% |
Koszty finansowe (mln) |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
7 |
4 |
5 |
1 |
1 |
EBITDA (mln) |
-6 |
-6 |
-9 |
-10 |
-14 |
-13 |
-6 |
-3 |
-2 |
-18 |
-8 |
12 |
-36 |
12 |
-9 |
43 |
-37 |
34 |
-17 |
-47 |
EBITDA(%) |
-448.3% |
-91.9% |
-59.5% |
-81.0% |
-187.5% |
-291.4% |
-47.2% |
-27.6% |
-17.7% |
-1967.8% |
-45.2% |
20.7% |
-109.2% |
15.5% |
-12.9% |
75.8% |
-304.5% |
68.0% |
-33.4% |
-371.7% |
Podatek (mln) |
0 |
1 |
0 |
0 |
0 |
0 |
1 |
-0 |
-0 |
-0 |
0 |
0 |
0 |
-0 |
0 |
7 |
14 |
41 |
-10 |
0 |
Zysk Netto (mln) |
-6 |
-6 |
-9 |
-10 |
-15 |
-14 |
-7 |
-3 |
-3 |
-20 |
-7 |
13 |
-48 |
3 |
-21 |
-71 |
-59 |
-99 |
-8 |
-49 |
Zysk netto Δ r/r |
0.0% |
-1.4% |
47.6% |
10.5% |
48.5% |
-6.6% |
-48.9% |
-54.2% |
-9.6% |
579.4% |
-65.9% |
-288.5% |
-482.8% |
-106.3% |
-787.6% |
237.5% |
-16.4% |
67.6% |
-92.4% |
553.5% |
Zysk netto (%) |
-471.5% |
-97.5% |
-62.4% |
-76.2% |
-189.6% |
-316.2% |
-59.5% |
-30.8% |
-23.2% |
-2166.2% |
-37.5% |
22.5% |
-148.3% |
3.8% |
-30.4% |
-124.5% |
-488.2% |
-199.6% |
-14.6% |
-392.0% |
EPS |
-0.41 |
-0.34 |
-0.36 |
-0.38 |
-0.56 |
-0.36 |
-0.19 |
-0.0846 |
-0.0747 |
-0.39 |
-0.13 |
0.23 |
-0.89 |
0.0519 |
-0.31 |
-0.9 |
-0.74 |
-1.24 |
-0.0941 |
-0.61 |
EPS (rozwodnione) |
-0.41 |
-0.34 |
-0.36 |
-0.38 |
-0.56 |
-0.36 |
-0.19 |
-0.0846 |
-0.0747 |
-0.39 |
-0.13 |
0.23 |
-0.89 |
0.0519 |
-0.31 |
-0.9 |
-0.74 |
-1.24 |
-0.0941 |
-0.61 |
Ilośc akcji (mln) |
15 |
18 |
25 |
26 |
26 |
37 |
38 |
38 |
39 |
50 |
52 |
54 |
54 |
59 |
67 |
79 |
80 |
80 |
80 |
81 |
Ważona ilośc akcji (mln) |
15 |
18 |
25 |
26 |
26 |
37 |
38 |
38 |
39 |
50 |
53 |
54 |
54 |
59 |
67 |
79 |
80 |
80 |
80 |
81 |
Waluta |
EUR |
EUR |
EUR |
EUR |
EUR |
EUR |
EUR |
EUR |
EUR |
EUR |
EUR |
EUR |
EUR |
EUR |
EUR |
EUR |
EUR |
EUR |
EUR |
EUR |